Actavis, Inc. (NYSE:ACT)

CAPS Rating: 4 out of 5

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

Recs

0
Player Avatar chris293 (87.76) Submitted: 10/24/2013 5:49:57 PM : Underperform Start Price: $146.30 ACT Score: -63.48

Some of these stocks I just do not understand. A lot of negatives, for example a minus ROI, among others? O.K. they made 6 cents.

Featured Broker Partners


Advertisement